{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?page=28&status=RECRUITING", "query": { "status": "RECRUITING", "page": 28 }, "page_size": 10 }, "pagination": { "page": 28, "page_size": 10, "total_count": 21991, "total_pages": 2200, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?page=29&status=RECRUITING&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?page=27&status=RECRUITING&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-06T22:17:01.747Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04998357", "title": "Autologous Mitochondrial Transplant for Cerebral Ischemia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cerebral Ischemia" ], "interventions": [ { "name": "Endovascular autologous mitochondrial transplantation", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 20, "start_date": "2021-04-29", "completion_date": "2026-10-29", "has_results": false, "last_update_posted_date": "2025-05-21", "last_synced_at": "2026-11-06T22:17:01.747Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT04998357" }, { "nct_id": "NCT07500727", "title": "Skeletal Muscle Aging and Responsiveness in Aged People With MS", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Multiple Sclerosis", "Aging" ], "interventions": [ { "name": "Exercise trial consisting of both cardiovascular and strength training", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Oklahoma Medical Research Foundation", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 10, "start_date": "2026-03-06", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2026-03-30", "last_synced_at": "2026-11-06T22:17:01.747Z", "location_count": 1, "location_summary": "Oklahoma City, Oklahoma", "locations": [ { "city": "Oklahoma City", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT07500727" }, { "nct_id": "NCT07400042", "title": "Peripheral Venous Pressure (PVP) Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Congestive Heart Failure" ], "interventions": [ { "name": "peripheral venous pressure measurements", "type": "OTHER" }, { "name": "standard clinical care", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 600, "start_date": "2026-10-05", "completion_date": "2031-10", "has_results": false, "last_update_posted_date": "2026-10-07", "last_synced_at": "2026-11-06T22:17:01.747Z", "location_count": 1, "location_summary": "Milwaukee, Wisconsin", "locations": [ { "city": "Milwaukee", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT07400042" }, { "nct_id": "NCT07294170", "title": "ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Myasthenia Gravis", "MG", "gMG", "Generalized Myasthenia Gravis", "Generalized Myasthenia Gravis (gMG)", "AChR-Ab Seropositive Generalized Myasthenia Gravis" ], "interventions": [ { "name": "Efgartigimod IV", "type": "BIOLOGICAL" }, { "name": "Empasiprubart IV", "type": "BIOLOGICAL" }, { "name": "Placebo IV", "type": "OTHER" }, { "name": "Efgartigimod PH20 SC PFS", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "argenx", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 70, "start_date": "2025-12-19", "completion_date": "2028-03-07", "has_results": false, "last_update_posted_date": "2026-10-26", "last_synced_at": "2026-11-06T22:17:01.747Z", "location_count": 15, "location_summary": "Carlsbad, California • Miami, Florida • Tampa, Florida + 11 more", "locations": [ { "city": "Carlsbad", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT07294170" }, { "nct_id": "NCT04903470", "title": "Defecation Patterns in Constipated Patients", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Constipation by Outlet Obstruction" ], "interventions": [ { "name": "Bisacodyl", "type": "DRUG" }, { "name": "Atropin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The California Medical Innovations Institute, Inc.", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "21 Years to 75 Years" }, "enrollment_count": 130, "start_date": "2022-12-19", "completion_date": "2026-12-30", "has_results": false, "last_update_posted_date": "2025-10-21", "last_synced_at": "2026-11-06T22:17:01.747Z", "location_count": 2, "location_summary": "San Diego, California • Augusta, Georgia", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Augusta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04903470" }, { "nct_id": "NCT05476770", "title": "Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hematologic Malignancy", "AML", "ALL", "BPDCN", "MDS", "Lymphoblastic Lymphoma", "Lymphoma, B-Cell", "Lymphoma, T-Cell", "Hodgkin Lymphoma", "Mixed Phenotype Acute Leukemia", "Acute Undifferentiated Leukemia" ], "interventions": [ { "name": "Tagraxofusp", "type": "DRUG" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "Cytarabine", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Vincristine", "type": "DRUG" }, { "name": "Azacitidine", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Cytarabine IT", "type": "DRUG" }, { "name": "Hydrocortisone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Therapeutic Advances in Childhood Leukemia Consortium", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "21 Years", "sex": "ALL", "summary": "1 Year to 21 Years" }, "enrollment_count": 54, "start_date": "2022-11-11", "completion_date": "2027-11-11", "has_results": false, "last_update_posted_date": "2024-12-06", "last_synced_at": "2026-11-06T22:17:01.747Z", "location_count": 29, "location_summary": "Los Angeles, California • Orange, California • San Francisco, California + 25 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05476770" }, { "nct_id": "NCT03451383", "title": "Older Breast Cancer Patients: Risk for Cognitive Decline", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cancer, Breast", "Age-related Cognitive Decline", "Cognitive Decline" ], "interventions": [], "intervention_types": [], "sponsor": "Georgetown University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "60 Years", "maximum_age": "105 Years", "sex": "FEMALE", "summary": "60 Years to 105 Years · Female only" }, "enrollment_count": 1700, "start_date": "2010-08-01", "completion_date": "2027-04-30", "has_results": false, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-11-06T22:17:01.747Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03451383" }, { "nct_id": "NCT07660094", "title": "Aglatimagene Besadenovec + Prodrug and Pembrolizumab vs Docetaxel for Stage IV Non-Squamous NSCLC Progressing on Pembrolizumab (AURORA)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Non-squamous, Non-Small Cell Lung Cancer" ], "interventions": [ { "name": "Aglatimagene Besadenovec", "type": "BIOLOGICAL" }, { "name": "Valacyclovir", "type": "DRUG" }, { "name": "Pembrolizumab", "type": "BIOLOGICAL" }, { "name": "Docetaxel", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Candel Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 500, "start_date": "2026-06-15", "completion_date": "2031-10-22", "has_results": false, "last_update_posted_date": "2026-06-22", "last_synced_at": "2026-11-06T22:17:01.747Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07660094" }, { "nct_id": "NCT07415954", "title": "A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "NNC0662-0419", "type": "DRUG" }, { "name": "Semaglutide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 270, "start_date": "2026-04-17", "completion_date": "2027-10-01", "has_results": false, "last_update_posted_date": "2026-09-11", "last_synced_at": "2026-11-06T22:17:01.747Z", "location_count": 23, "location_summary": "Lancaster, California • Lomita, California • Long Beach, California + 20 more", "locations": [ { "city": "Lancaster", "state": "California" }, { "city": "Lomita", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Alamitos", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07415954" }, { "nct_id": "NCT07613294", "title": "A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atherosclerosis", "Cardiovascular Diseases", "Lipoprotein(a)" ], "interventions": [ { "name": "Lepodisiran", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "45 Years to 80 Years" }, "enrollment_count": 252, "start_date": "2026-06-01", "completion_date": "2029-12", "has_results": false, "last_update_posted_date": "2026-11-04", "last_synced_at": "2026-11-06T22:17:01.747Z", "location_count": 17, "location_summary": "La Jolla, California • Northridge, California • Torrance, California + 14 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Northridge", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07613294" } ] }